Treatment of bone metastases in breast cancer patients
Journal Title: Współczesna Onkologia - Year 2006, Vol 10, Issue 8
Abstract
Bone metastases are a major problem in the clinical management of patients with breast cancer. With prolongation of survival, the challenge is to improve the quality of the patient’s remaining life. The treatment of metastatic bone disease requires a multidisciplinary approach that addresses systemic and focal disease. The complex nature of metastatic disease requires the combined efforts of a team of clinical, radiation, and orthopaedic oncologists. Prevention and treatment of skeletal complications requires early detection and aggressive management. Focal complications are best treated with both surgery and radiotherapy. Systemic disease and complications are best addressed with hormonal therapy, chemotherapy, and bisphosphonate therapy. External-beam radiotherapy has become a mainstay in the palliative treatment of metastatic bone disease. The indications for radiotherapy are the relief of pain and the control of localized disease. Bisphosphonates, as inhibitors of osteoclast activity, are very effective in the prevention of skeletal complications and hypercalcaemia.
Authors and Affiliations
Wojciech Pawlak, Marlena Wawrocka-Pawlak
Keywords
Related Articles
- EP ID EP144382
- DOI -
- Views 69
- Downloads 0
The orbital tumors - some problems in diagnostics and treatment
A particularly unfavorable localization of a malignant tumor for the patient is the localization in vicinity of the orbital cavity. Besides the oncological problems, some other disturbances like ophthalmological concerne...
Medulloblastoma u 38-letniego mężczyzny. Opis przypadku i przegląd literatury
Medulloblastoma, złośliwy guz neuroektodermalny, jest rzadko spotykany u dorosłych i stanowi ok. 1 proc. wszystkich guzów centralnego układu nerwowego. Standardem postępowania jest maksymalne usunięcie guza, z pooperacyj...
Aktywność β-galaktozydazy i α-mannozydazy w surowicy krwi chorych z rakiem jelita grubego
β-galaktozydaza (GAL) i a-mannozydaza (MAN) są egzoglikozydazami lizosomalnymi uczestniczącymi w syntezie glikokoniugatów w siateczce endoplazmatycznej oraz aparacie Golgiego i ich degradacji w lizosomach. W chorobach no...
Biochemical failure in prostate cancer following radiation therapy
Within 5 years, the rate of biochemical progression of the disease ranges from 5% to 20% for men with favorable-risk disease after interstitial or external irradiation, to as high as 30% to 60% for men with intermediate...
Rola radioterapii w leczeniu chorych z przerzutami raka płaskonabłonkowego do węzłów chłonnych szyjnych z nieznanego ogniska pierwotnego
Przedstawiono wyniki retrospektywnej analizy grupy 127 chorych z przerzutami raka płaskonabłonkowego do węzłów chłonnych szyjnych z nieznanego ogniska pierwotnego, leczonych radykalnie w Centrum Onkologii w Krakowie w la...